OPRX - OptimizeRx Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
11.95
+0.35 (+3.02%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close11.60
Open11.57
Bid11.82 x 800
Ask11.95 x 1800
Day's Range11.57 - 12.87
52 Week Range1.12 - 18.39
Volume31,205
Avg. Volume51,944
Market Cap143.564M
Beta (3Y Monthly)0.39
PE Ratio (TTM)1,327.78
EPS (TTM)0.01
Earnings DateMay 11, 2017 - May 12, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est23.33
Trade prices are not sourced from all markets
  • GlobeNewswire14 days ago

    OptimizeRx Joins MSCI USA Microcap Index

    OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, joined the MSCI USA Microcap Index at the conclusion of the MSCI indexes semi-annual reconstitution, effective after the U.S. market closes today, according to the MSCI website. “Joining the MSCI USA Microcap Index represents another major market milestone for OptimizeRx after our up-listing to Nasdaq earlier this year,” said OptimizeRx CEO, William Febbo.

  • ACCESSWIRE16 days ago

    OptimizeRx to Present at 11th Annual LD Micro Main Event on December 4-6, 2018

    ROCHESTER, MI / ACCESSWIRE / November 28, 2018 / OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to present at 11th Annual LD Micro Main Event institutional investor conference being held on December 4-6, 2018 at the Luxe Sunset Bel Air Hotel in Bel Air, California. William Febbo, CEO of OptimizeRx, is scheduled to present on Tuesday, December 4, at 1:30 p.m. Pacific time, with one-on-one meetings with institutional analysts and investors. The presentation will be also webcast live and available for replay here and via the investor relations section of the company's website at www.optimizerx.com.

  • Do Institutions Own OptimizeRx Corporation (NASDAQ:OPRX) Shares?
    Simply Wall St.28 days ago

    Do Institutions Own OptimizeRx Corporation (NASDAQ:OPRX) Shares?

    The big shareholder groups in OptimizeRx Corporation (NASDAQ:OPRX) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership Read More...

  • GlobeNewswire29 days ago

    Recent Analysis Shows Construction Partners, OptimizeRx, OncoMed Pharmaceuticals, Issuer Direct, Red Violet, and Golden Minerals Market Influences — Renewed Outlook, Key Drivers of Growth

    NEW YORK, Nov. 15, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • GlobeNewswirelast month

    OptimizeRx to Ring Nasdaq Closing Bell on Friday, November 16

    OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to ring the Nasdaq Stock Market Closing Bell on Friday, November 16, to commemorate the company’s recent market uplisting. In honor of the occasion, William Febbo, CEO of OptimizeRx, will ring the closing bell at the Nasdaq Market site in Times Square, where he will be joined by other members of the OptimizeRx team.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of OPRX earnings conference call or presentation 5-Nov-18 9:30pm GMT

    Q3 2018 OPTIMIZERx Corp Earnings Call

  • GlobeNewswirelast month

    OptimizeRx Reports Third Quarter 2018 Results; Net Revenue Up 75% to a Record $5.4 Million, Driving $0.02 EPS

    ROCHESTER, Mich., Nov. 05, 2018 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the.

  • OptimizeRx (OPRX) Q3 Earnings Preview: What to Look Out For
    Zacks2 months ago

    OptimizeRx (OPRX) Q3 Earnings Preview: What to Look Out For

    OptimizeRx (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire2 months ago

    OptimizeRx to Present at ROTH Technology Corporate Access Day on November 14, 2018

    OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate in the 4th Annual ROTH Technology Corporate Access Day being hosted by ROTH Capital Partners on November 14, 2018 at the Empire Steak House in New York City. OptimizeRx CEO William Febbo will discuss a number of topics, including the company’s results for the third quarter of 2018, recent acquisition of CareSpeak Communications, and the growth of the company’s digital health network. The network is the largest of its kind, reaching more than half of the ambulatory patient market in the U.S.

  • GlobeNewswire2 months ago

    OptimizeRx Acquires CareSpeak Communications

    OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has acquired CareSpeak Communications, a leader in interactive health messaging for improved medication adherence and care coordination. OptimizeRx bridges the communication gap between pharma and providers with its digital health messaging platform that is delivered through a nationwide network of leading electronic health record (EHR) and ePrescribing providers.

  • Simply Wall St.2 months ago

    Are OptimizeRx Corporation’s (NASDAQ:OPRX) Interest Costs Too High?

    Zero-debt allows substantial financial flexibility, especially for small-cap companies like OptimizeRx Corporation (NASDAQ:OPRX), as the company does not have to adhere to strict debt covenants. However, it also faces higher Read More...

  • GlobeNewswire2 months ago

    OptimizeRx Invited to Co-Host Plenary Session at Digital Pharma East on October 17, 2018

    OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to speak at the 12th Annual Digital Pharma East conference being held at the Pennsylvania Convention Center in Philadelphia on October 16-19, 2018. Bringing together more than 1,000 participants, this conference will feature latest case studies and senior-level discussions with pharma companies, health systems, physicians, health-tech companies, startups and non-traditional healthcare companies involved in digital health. A plenary session, “Addressing Medication Adherence to Improve Quality of Care,” will be co-hosted by Miriam Paramore, president of OptimizeRx, at 5:00 p.m. Eastern time on October 17.

  • ACCESSWIRE2 months ago

    MicroCap Review Magazine Fall 2018 Issue Now Available

    The Digital Issue of the Fall 2018 MicroCap Review Magazine, The Official Magazine for the MicroCap Stock Market, can be read on www.StockNewsNow.com LOS ANGELES, CA / ACCESSWIRE / October 9, 2018 / SNN ...

  • Zacks.com highlights: OptimizeRX, Verso, BioSpecifics Technologies and Luxfer Holdings
    Zacks2 months ago

    Zacks.com highlights: OptimizeRX, Verso, BioSpecifics Technologies and Luxfer Holdings

    Zacks.com highlights: OptimizeRX, Verso, BioSpecifics Technologies and Luxfer Holdings

  • 4 Stocks With Recent Price Strength to Maximize Your Gains
    Zacks2 months ago

    4 Stocks With Recent Price Strength to Maximize Your Gains

    Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

  • GlobeNewswire3 months ago

    OptimizeRx Partners with Medicom Health to Bring Automated Medication Savings Directly to Patients at Hospitals Nationwide

    ROCHESTER, Mich., Sept. 27, 2018-- OptimizeRx Corp., a leading provider of digital health messaging for the pharmaceutical industry, has partnered with Medicom Health, a software company that creates evidence-based ...

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of OPRX earnings conference call or presentation 7-Aug-18 8:30pm GMT

    Q2 2018 OPTIMIZERx Corp Earnings Call

  • ACCESSWIRE4 months ago

    OptimizeRx Corporation to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 7, 2018 / OptimizeRx Corporation (NASDAQ: OPRX ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 4:30 PM Eastern Time. ...